Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Other3

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Antiphospholipid Syndrome
StudydirectorStart date: 2022-10-01
NCT04928586Phase 4Unknown
Immunosuppressant Combined With Pirfenidone in CTD-ILD
Connective Tissue DiseasesInterstitial Lung DiseasePirfenidone
PrincipalinvestigatorStart date: 2019-08-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05644210StudyDirector

Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

Antiphospholipid Syndrome
Unknown
NCT05527444Phase 4StudyDirector

The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients

Ankylosing Spondylitis
Unknown
NCT04928586Phase 4PrincipalInvestigator

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Connective Tissue DiseasesInterstitial Lung DiseasePirfenidone
Unknown

All 3 trials loaded